Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

IGF-I in the clinics: Use… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

IGF-I in the clinics: Use in retinopathy of prematurity

Artikel i vetenskaplig tidskrift
Författare Ann Hellström
D. Ley
I. Hansen-Pupp
B. Hallberg
L. A. Ramenghi
Chatarina Löfqvist
L. E. H. Smith
A. L. Hard
Publicerad i Growth Hormone & Igf Research
Volym 30-31
Sidor 75-80
ISSN 1096-6374
Publiceringsår 2016
Publicerad vid Institutionen för neurovetenskap och fysiologi, sektionen för klinisk neurovetenskap och rehabilitering
Sidor 75-80
Språk en
Länkar dx.doi.org/10.1016/j.ghir.2016.09.0...
Ämnesord Fetus, Preterm infant, Postnatal growth, IGF-1, Metabolism, Preterm morbidity, growth-factor-i, oxygen-induced retinopathy, factor-binding-proteins, vascular endothelial-cells, extremely preterm infants, retinal, neovascularization, saturation targets, human-fetus, glucose-transport, postnatal weight, Cell Biology
Ämneskategorier Klinisk medicin

Sammanfattning

Retinopathy of prematurity is a potentially blinding disease, which is associated with low neonatal IGF-I serum concentrations and poor growth. In severe cases impaired retinal vessel growth is followed by pathologic neovascularization, which may lead to retinal detachment. IGF-I may promote growth even in catabolic states. Treating preterm infants with recombinant human (rh) IGF-I to concentrations normally found during gestation has been suggested to have a preventative effect on ROP. A recent phase 2 study treating infants (gestational age between 23 weeks + 0 days and 27 weeks +6 days) with rhIGF-I/IGF binding protein-3 until 30 postmenstrual weeks showed no effect on ROP but a 53% reduction in severe bronchopulmonary dysplasia and 44% reduction in severe intraventricular hemorrhage. Oxygen is a major risk factor for ROP and during the phase 2 study oxygen saturation targets were increased to 90-95%, due to national guidelines, which might have affected ROP rate and severity making increased IGF-I a weaker preventative factor for ROP.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?